Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.

Basit Öğe Kaydı
dc.authoridBeksac, Meral/0000-0003-1797-8657
dc.authoridKAYA, Emin/0000-0001-8605-8497
dc.authoridAladag, Elifcan/0000-0002-1206-9908
dc.authoridÖZDOĞU, HAKAN/0000-0002-8902-1283
dc.authorwosidBeksac, Meral/D-6411-2013
dc.authorwosidKAYA, Emin/W-2951-2017
dc.authorwosidAladag, Elifcan/ABA-4185-2020
dc.authorwosidÖZDOĞU, HAKAN/AAD-5542-2021
dc.contributor.authorBeksac, Meral
dc.contributor.authorHaznedar, Rauf
dc.contributor.authorFiratli-Tuglular, Tulin
dc.contributor.authorOzdogu, Hakan
dc.contributor.authorAydogdu, Ismet
dc.contributor.authorKonuk, Nahide
dc.contributor.authorSucak, Gulsan
dc.date.accessioned2024-08-04T20:56:23Z
dc.date.available2024-08-04T20:56:23Z
dc.date.issued2009
dc.departmentİnönü Üniversitesien_US
dc.description51st Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2009 -- New Orleans, LAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Hematolen_US
dc.identifier.endpage747en_US
dc.identifier.issn0006-4971
dc.identifier.issue22en_US
dc.identifier.startpage746en_US
dc.identifier.urihttps://hdl.handle.net/11616/102277
dc.identifier.volume114en_US
dc.identifier.wosWOS:000272725802248en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Hematologyen_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleAddition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu